시장보고서
상품코드
1017286

인공 각막 및 각막 임플란트 시장 기회 분석과 산업 예측(2021-2028년) : 각막 유형, 이식 유형, 적응증, 최종사용자, 지역별

Artificial Cornea and Corneal Implant Market by Type, Transplant Type, Disease Indication, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2028

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 215 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 인공 각막 및 각막 임플란트 시장 규모는 예측 기간 중 7.9%의 CAGR로 추이하며, 2020년 3억 7661만 달러에서 2028년에는 6억 5619만 달러 규모로 성장할 것으로 예측됩니다.

고령자 인구의 증가, 안질환의 급증, 정부 구상 등의 요인이 이 시장의 성장을 촉진하고 있습니다. 한편, 안과의료기기 및 외과수술의 고비용이 예측 기간 중 시장 성장을 억제할 것으로 예측됩니다.

세계의 인공 각막 및 각막 임플란트 시장을 조사했으며, 시장의 정의와 개요, 신종 코로나바이러스 감염증(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모의 추이·예측, 각막 유형·이식 유형·적응증·최종사용자·지역/주요 국가 등 각종 부문별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 서론

제2장 개요

제3장 시장 개요

  • 시장의 정의·범위
  • 주요 조사 결과
  • Porter의 산업 분석
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
  • COVID-19 : 영향 분석

제4장 시장 분석·예측 : 각막 유형별

  • 인간 각막
  • 인공 각막
    • 주요 동향·성장 기회
    • 시장 규모·예측
    • 시장 분석 : 국가별

제5장 시장 분석·예측 : 이식 유형별

  • 각막이식
  • 내피각막이식
  • 전부층상 각막이식(Anterior lamellar keratoplasty)
  • 인공각막이식(keratoprosthesis)
    • 시장 규모·예측
    • 시장 분석 : 국가별

제6장 시장 분석·예측 : 적응증별

  • Fuchs' Dystrophy
  • 진균성 각막염
  • 원추각막
  • 기타
    • 시장 규모·예측
    • 시장 분석 : 국가별

제7장 시장 분석·예측 : 최종사용자별

  • 병원·외래 수술 센터
  • 전문 클리닉
    • 시장 규모·예측
    • 시장 분석 : 국가별

제8장 시장 분석·예측 : 지역·주요 국가별

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카·중동·아프리카
    • 주요 동향·성장 기회
    • 시장 규모·예측 : 국가별
    • 시장 규모·예측 : 각막 유형별
    • 시장 규모·예측 : 이식 유형별
    • 시장 규모·예측 : 적응증별
    • 시장 규모·예측 : 최종사용자별

제9장 기업 개요

  • AJL Ophthalmic
  • CorneaGen Inc
  • CorNeat Vision
  • LinkoCare Life Sciences AB
  • Presbia plc
  • Mediphacos
  • Aurolab
  • Cornea Biosciences
  • DIOPTEX GmbH
  • EyeYon Medical
KSA 21.07.15

The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea.

The global artificial cornea and corneal implant market is expected to witness a substantial growth in the future, driven by the rise in geriatric population and surge in prevalence of eye diseases. In addition, increase in prevalence of eye disorders and government initiatives to control visual impairment further boost the market growth. However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of the market during the forecast period.

Around 10 million people in world are reported to suffer from corneal blindness. Therefore, rise in incidences of corneal blindness is the primary factor that drives the growth of the artificial cornea implant market. Moreover, lack of availability of human cornea donor is responsible for the robust growth of the market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth. The possibility of nerve regeneration after cornea transplant by human donor cornea is low while the possibility of nerve regeneration after biosynthetic cornea implant is high. The rejection of artificial cornea made up of alloplastic material by human eye is expected to be the major factor that restrains the growth of the market. Artificial cornea implant is a costly surgery, therefore the adoption for this surgery is quite low in the developing countries which deters the growth of the market during the forecast period. In addition, low availability of human cornea donor and high risk in the grafting artificial cornea implant have made a huge impact in the global market.

The artificial cornea and corneal implant market is segmented on the basis of type, transplant type, disease indication, end user, and region. By type, the market is divided into human cornea and artificial cornea. By transplant type, it is categorized into penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty and keratoprosthesis. By disease indication, the market is divided into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and others. By end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA)..

The key players operating in the global artificial cornea and corneal implant market include AJL Ophthalmic, CorneaGen Inc., CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH, EyeYon Medical.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the artificial cornea and corneal implant market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2020 to 2028 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the trends in artificial cornea and corneal implant globally
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Type

  • Human Cornea
  • Artificial Cornea

By Transplant Type

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Anterior lamellar keratoplasty
  • keratoprosthesis

By Disease Indication

  • Fuchs' Dystrophy
  • Fungal Keratitis
  • Keratoconus
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • AJL Ophthalmic
  • CorneaGen Inc.
  • CorNeat Vision
  • LinkoCare Life Sciences AB
  • Presbia plc
  • Mediphacos
  • Aurolab
  • Cornea Biosciences
  • DIOPTEX GmbH
  • EyeYon Medical

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key Findings of the Study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market dynamics
    • 3.4.1.Drivers
      • 3.4.1.1.Rise in prevalence of eye diseases across the globe
      • 3.4.1.2.Surge in government initiatives to control visual impairment
      • 3.4.1.3.Growth in geriatric population
    • 3.4.2.Restraints
      • 3.4.2.1.High cost of ophthalmology devices and surgical procedures
      • 3.4.2.2.Low accessibility to eye care in low income countries
    • 3.4.3.Opportunity
      • 3.4.3.1.Shortage of corneal donors
  • 3.5.COVID-19 impact on the artificial cornea and corneal implant market

CHAPTER 4:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Human Cornea
    • 4.2.1.Key market trends and growth opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.Artificial Cornea
    • 4.3.1.Key market trends and growth opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country

CHAPTER 5:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Penetrating Keratoplasty
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Endothelial Keratoplasty
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country
  • 5.4.Anterior lamellar keratoplasty
    • 5.4.1.Market size and forecast
    • 5.4.2.Market analysis, by country
  • 5.5.keratoprosthesis
    • 5.5.1.Market size and forecast
    • 5.5.2.Market analysis, by country

CHAPTER 6:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Fuchs' Dystrophy
    • 6.2.1.Market size and forecast
    • 6.2.2.Market analysis, by country
  • 6.3.FUNGAL KERATITIS
    • 6.3.1.Market size and forecast
    • 6.3.2.Market analysis, by country
  • 6.4.Keratoconus
    • 6.4.1.Market size and forecast
    • 6.4.2.Market analysis, by country
  • 6.5.Other Diseases
    • 6.5.1.Market size and forecast
    • 6.5.2.Market analysis, by country

CHAPTER 7:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Hospitals & Ambulatory Surgical Centers
    • 7.2.1.Market size and forecast
    • 7.2.2.Market analysis, by country
  • 7.3.Specialty Clinics
    • 7.3.1.Market size and forecast
    • 7.3.2.Market analysis, by country

CHAPTER 8:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Key market trends and opportunities
    • 8.2.2.Market size and forecast, by country
    • 8.2.3.North America artificial cornea and corneal implant market by Type
    • 8.2.4.North America artificial cornea and corneal implant market by Transplant Type
    • 8.2.5.North America artificial cornea and corneal implant market by Disease Indication
    • 8.2.6.North America artificial cornea and corneal implant market by end user
      • 8.2.6.1.U.S.
      • 8.2.6.1.1.U.S. artificial cornea and corneal implant market by Type
      • 8.2.6.1.2.U.S. artificial cornea and corneal implant market by Transplant Type
      • 8.2.6.1.3.U.S. artificial cornea and corneal implant market by Disease Indication
      • 8.2.6.1.4.U.S. artificial cornea and corneal implant market by end user
      • 8.2.6.2.Canada
      • 8.2.6.2.1.Canada artificial cornea and corneal implant market by Type
      • 8.2.6.2.2.Canada artificial cornea and corneal implant market by Transplant Type
      • 8.2.6.2.3.Canada artificial cornea and corneal implant market by Disease Indication
      • 8.2.6.2.4.Canada artificial cornea and corneal implant market by end user
      • 8.2.6.3.Mexico
      • 8.2.6.3.1.Mexico artificial cornea and corneal implant market by Type
      • 8.2.6.3.2.Mexico artificial cornea and corneal implant market by Transplant Type
      • 8.2.6.3.3.Mexico artificial cornea and corneal implant market by Disease Indication
      • 8.2.6.3.4.Mexico artificial cornea and corneal implant market by end user
  • 8.3.Europe
    • 8.3.1.Key market trends and opportunities
    • 8.3.2.Market size and forecast, by country
    • 8.3.3.Europe artificial cornea and corneal implant market by Type
    • 8.3.4.Europe artificial cornea and corneal implant market by Transplant Type
    • 8.3.5.Europe artificial cornea and corneal implant market by Disease Indication
    • 8.3.6.Europe artificial cornea and corneal implant market by end user
      • 8.3.6.1.Germany
      • 8.3.6.1.1.Germany artificial cornea and corneal implant market by Type
      • 8.3.6.1.2.Germany artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.1.3.Germany artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.1.4.Germany artificial cornea and corneal implant market by end user
      • 8.3.6.2.France
      • 8.3.6.2.1.France artificial cornea and corneal implant market by Type
      • 8.3.6.2.2.France artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.2.3.France artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.2.4.France artificial cornea and corneal implant market by end user
      • 8.3.6.3.UK
      • 8.3.6.3.1.UK artificial cornea and corneal implant market by Type
      • 8.3.6.3.2.UK artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.3.3.UK artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.3.4.UK artificial cornea and corneal implant market by end user
      • 8.3.6.4.Rest of Europe
      • 8.3.6.4.1.Rest of Europe artificial cornea and corneal implant market by Type
      • 8.3.6.4.2.Rest of Europe artificial cornea and corneal implant market by Transplant Type
      • 8.3.6.4.3.Rest of Europe artificial cornea and corneal implant market by Disease Indication
      • 8.3.6.4.4.Rest of Europe artificial cornea and corneal implant market by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Key market trends and opportunities
    • 8.4.2.Market size and forecast, by country
    • 8.4.3.Asia-Pacific artificial cornea and corneal implant market by Type
    • 8.4.4.Asia-Pacific artificial cornea and corneal implant market, by Transplant Type
    • 8.4.5.Asia-Pacific artificial cornea and corneal implant market, by Disease Indication
    • 8.4.6.Asia-Pacific artificial cornea and corneal implant market by end user
      • 8.4.6.1.Japan
      • 8.4.6.1.1.Japan artificial cornea and corneal implant market by Type
      • 8.4.6.1.2.Japan artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.1.3.Japan artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.1.4.Japan artificial cornea and corneal implant market by end user
      • 8.4.6.2.China
      • 8.4.6.2.1.China artificial cornea and corneal implant market by Type
      • 8.4.6.2.2.China artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.2.3.China artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.2.4.China artificial cornea and corneal implant market by end user
      • 8.4.6.3.Australia
      • 8.4.6.3.1.Australia artificial cornea and corneal implant market by Type
      • 8.4.6.3.2.Australia artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.3.3.Australia artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.3.4.Australia artificial cornea and corneal implant market by end user
      • 8.4.6.4.India
      • 8.4.6.4.1.India artificial cornea and corneal implant market by Type
      • 8.4.6.4.2.India artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.4.3.India artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.4.4.India artificial cornea and corneal implant market by end user
      • 8.4.6.5.Rest of Asia-Pacific
      • 8.4.6.5.1.Rest of Asia-Pacific artificial cornea and corneal implant market by Type
      • 8.4.6.5.2.Rest of Asia-Pacific artificial cornea and corneal implant market by Transplant Type
      • 8.4.6.5.3.Rest of Asia-Pacific artificial cornea and corneal implant market by Disease Indication
      • 8.4.6.5.4.Rest of Asia-Pacific artificial cornea and corneal implant market by end user
  • 8.5.LAMEA
    • 8.5.1.Key market trends and opportunities
    • 8.5.2.Market size and forecast, by country
    • 8.5.3.LAMEA artificial cornea and corneal implant market by Type
    • 8.5.4.LAMEA artificial cornea and corneal implant market by Transplant Type
    • 8.5.5.LAMEA artificial cornea and corneal implant market by Disease Indication
    • 8.5.6.LAMEA artificial cornea and corneal implant market by end user
      • 8.5.6.1.Brazil
      • 8.5.6.1.1.Brazil artificial cornea and corneal implant market by Type
      • 8.5.6.1.2.Brazil artificial cornea and corneal implant market by Transplant Type
      • 8.5.6.1.3.Brazil artificial cornea and corneal implant market by Disease Indication
      • 8.5.6.1.4.Brazil artificial cornea and corneal implant market by end user
      • 8.5.6.2.Saudi Arabia
      • 8.5.6.2.1.Saudi Arabia artificial cornea and corneal implant market, by Type
      • 8.5.6.2.2.Saudi Arabia artificial cornea and corneal implant market, by Transplant Type
      • 8.5.6.2.3.Saudi Arabia artificial cornea and corneal implant market, by Disease Indication
      • 8.5.6.2.4.Saudi Arabia artificial cornea and corneal implant market, by end user
      • 8.5.6.3.South Africa
      • 8.5.6.3.1.South Africa artificial cornea and corneal implant market by Type
      • 8.5.6.3.2.South Africa artificial cornea and corneal implant market, by Transplant Type
      • 8.5.6.3.3.South Africa artificial cornea and corneal implant market, by Disease Indication
      • 8.5.6.3.4.South Africa artificial cornea and corneal implant market, by end user
      • 8.5.6.4.Rest of LAMEA
      • 8.5.6.4.1.Rest of LAMEA artificial cornea and corneal implant market by Type
      • 8.5.6.4.2.Rest of LAMEA artificial cornea and corneal implant market by Transplant Type
      • 8.5.6.4.3.Rest of LAMEA artificial cornea and corneal implant market by Disease Indication
      • 8.5.6.4.4.Rest of LAMEA artificial cornea and corneal implant market by end user

CHAPTER 9:COMPANY PROFILES

  • 9.1.AJL Ophthalmic
    • 9.1.1.Company overview
    • 9.1.2.Company snapshot
    • 9.1.4.Product portfolio
  • 9.2.CorneaGen Inc
    • 9.2.1.Company overview
    • 9.2.2.Company snapshot
    • 9.2.3.Operating business segment
    • 9.2.4.Product portfolio
    • 9.2.5.Key strategic moves and developments
  • 9.3.CorNeat Vision
    • 9.3.1.Company overview
    • 9.3.2.Company snapshot
    • 9.3.3.Operating business segments
    • 9.3.4.Product portfolio
  • 9.4.LinkoCare Life Sciences AB
    • 9.4.1.Company overview
    • 9.4.2.Company snapshot
    • 9.4.3.Operating business segments
    • 9.4.4.Product portfolio
  • 9.5.Presbia plc
    • 9.5.1.Company overview
    • 9.5.2.Operating business segments
    • 9.5.3.Product portfolio
  • 9.6.Mediphacos
    • 9.6.1.Company overview
    • 9.6.2.Company snapshot
    • 9.6.3.Operating business segments
    • 9.6.4.Product portfolio
  • 9.7.Aurolab
    • 9.7.1.Company overview
    • 9.7.2.Company snapshot
    • 9.7.3.Operating business segments
    • 9.7.4.Product portfolio
    • 9.7.5.Business performance
  • 9.8.Cornea Biosciences
    • 9.8.1.Company snapshot
    • 9.8.2.Operating business segments
    • 9.8.3.Product portfolio
  • 9.9.DIOPTEX GmbH
    • 9.9.1.Company overview
    • 9.9.2.Company snapshot
    • 9.9.3.Operating business segments
    • 9.9.4.Product portfolio
  • 9.10.EyeYon Medical
    • 9.10.1.Company overview
    • 9.10.2.Company snapshot
    • 9.10.3.Operating business segments
    • 9.10.4.Product portfolio
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제